These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 18398663)
1. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Lahat G; Anaya DA; Wang X; Tuvin D; Lev D; Pollock RE Ann Surg Oncol; 2008 Jun; 15(6):1585-93. PubMed ID: 18398663 [TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Mussi C; Collini P; Miceli R; Barisella M; Mariani L; Fiore M; Casali PG; Gronchi A Cancer; 2008 Oct; 113(7):1657-65. PubMed ID: 18704991 [TBL] [Abstract][Full Text] [Related]
3. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Singer S; Antonescu CR; Riedel E; Brennan MF Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502 [TBL] [Abstract][Full Text] [Related]
4. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas. Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768 [TBL] [Abstract][Full Text] [Related]
5. Computed tomography scan-driven selection of treatment for retroperitoneal liposarcoma histologic subtypes. Lahat G; Madewell JE; Anaya DA; Qiao W; Tuvin D; Benjamin RS; Lev DC; Pollock RE Cancer; 2009 Mar; 115(5):1081-90. PubMed ID: 19156920 [TBL] [Abstract][Full Text] [Related]
6. Significance of loss of heterozygosity of the RB1 gene during tumour progression in well-differentiated liposarcomas. Schneider-Stock R; Boltze C; Jaeger V; Stumm M; Seiler C; Rys J; Schütze K; Roessner A J Pathol; 2002 Aug; 197(5):654-60. PubMed ID: 12210086 [TBL] [Abstract][Full Text] [Related]
7. [Results of surgical therapy of primary and recurrent retroperitoneal liposarcoma]. Hiller WF; Jähne J; Tusch G; Meyer HJ; Pichlmayr R Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():234-6. PubMed ID: 9101841 [TBL] [Abstract][Full Text] [Related]
8. Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma. Gronchi A; Collini P; Miceli R; Valeri B; Renne SL; Dagrada G; Fiore M; Sanfilippo R; Barisella M; Colombo C; Morosi C; Stacchiotti S; Casali PG; Dei Tos AP; Pilotti S Am J Surg Pathol; 2015 Mar; 39(3):383-93. PubMed ID: 25581729 [TBL] [Abstract][Full Text] [Related]
9. Primary retroperitoneal liposarcoma: clinical and histological analysis of ten cases. Fernández-Ruiz M; Rodríguez-Gil Y; Guerra-Vales JM; Manrique-Municio A; Moreno-González E; Colina-Ruizdelgado F Gastroenterol Hepatol; 2010 May; 33(5):370-6. PubMed ID: 20206410 [TBL] [Abstract][Full Text] [Related]
10. Dedifferentiation within well-differentiated liposarcoma of the extremity or trunk: Implications for clinical management. Tseng WW; Barretta F; Baia M; Barisella M; Radaelli S; Callegaro D; Yoon DH; Fiore M; Gronchi A J Surg Oncol; 2021 Oct; 124(5):838-845. PubMed ID: 34254688 [TBL] [Abstract][Full Text] [Related]
11. Surgical management of primary and recurrent retroperitoneal liposarcoma. Neuhaus SJ; Barry P; Clark MA; Hayes AJ; Fisher C; Thomas JM Br J Surg; 2005 Feb; 92(2):246-52. PubMed ID: 15505870 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of aggressive surgical treatment of primary and recurrent retroperitoneal liposarcomas. Marinello P; Montresor E; Iacono C; Bortolasi L; Acerbi A; Facci E; Martignoni G; Brunelli M; Mainente M; Serio G Chir Ital; 2001; 53(2):149-57. PubMed ID: 11396061 [TBL] [Abstract][Full Text] [Related]